IMR Press / FBL / Volume 16 / Issue 6 / DOI: 10.2741/3848

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
An extended Myc network contributes to glucose homeostasis in cancer and diabetes
Show Less
1 Huntsman Cancer Institute, Department of Oncological Sciences, University of Utah, Room 4365, 2000 Circle of Hope, Salt Lake City, UT 84112-5550, USA
Front. Biosci. (Landmark Ed) 2011, 16(6), 2206–2223; https://doi.org/10.2741/3848
Published: 1 June 2011
Abstract

The Myc network of transcription factors plays pleiotropic roles in normal and pathological cell function. The canonical Myc network controls how the essential nutrients glucose and glutamine are utilized inside cells. The Myc network carries out this function by upregulating glucose and glutamine transporters and key enzymes in the glycolytic or glutaminolytic pathways. The Myc network also coordinates cellular utilization of glucose and glutamine in biosynthetic pathways by directly regulating mitochondrial mass and activity. We present an argument for the existence of an "extended" Myc network comprised of two related transcription factors MondoA and ChREBP. Both MondoA and ChREBP sense glycolytic flux and are the principal regulators of glucose-dependent transcription in their respective tissues, skeletal muscle and liver. MondoA also senses glutaminolytic flux into the tricarboxylic acid cycle and appears to coordinate the utilization of glucose and glutamine by regulating expression of thioredoxin interacting protein. Current data suggest that the extended Myc network regulates the cellular response to changes in nutrient availability and may be altered in cancer and insulin resistance.

Share
Back to top